Philips and Ibex Broaden Partnership to Strengthen AI-Driven Pathology and Elevate Patient Care
Royal Philips, a global leader in health technology, has expanded its partnership with Ibex Medical Analytics (Ibex) and released an updated version of its IntelliSite Pathology Solution (PIPS 6.0). This collaboration aims to accelerate the adoption of AI-enabled digital pathology and support clinicians facing growing workloads due to the global shortage of pathologists and the rising incidence of cancer.
Building on their partnership initiated in 2021, Philips and Ibex now offer deeper interoperability between their solutions to enhance diagnostic workflows and improve patient care. The latest integration of Ibex’s AI tools with Philips' digital pathology systems provides pathologists with improved diagnostic accuracy, increased efficiency, and optimized productivity.
Ibex’s AI technology, combined with Philips' digital pathology platform, has demonstrated up to 37% improvement in reporting efficiency and productivity [1]. Through this partnership, pathology labs can access the full range of Philips scanners and Image Management System alongside Ibex’s AI-powered diagnostic tools for prostate, breast, and gastric cancers.
“Pathology provides key information for a precise diagnosis. The Philips and Ibex solutions are especially beneficial to the diagnosis of cancer cases because they aid our pathologists in making an accurate and quick diagnosis,” said Sam Terese, President & CEO of Alverno Laboratories. “These integrated pathology solutions help us provide the highest possible quality result that any lab can deliver, getting answers back to our clinicians quickly and saving patients sleepless nights, even on complex cases.”
With enhanced interoperability, the combined Philips-Ibex solutions support advanced workflow optimization, AI-driven cancer detection, case prioritization, and improved diagnostic confidence. The goal is to provide efficient, reproducible, and scalable digital pathology systems to meet increasing clinical demand.
Philips’ new IntelliSite Pathology 6.0 system introduces several advanced features and capabilities [2], including contextual AI launch tools, enhanced navigation, and support for full scan mode on the pathology SG scanner. AI-focused worklists display real-time processing status, and slides are automatically shared with Ibex AI systems post-digitization, streamlining the diagnostic process.
“The enhanced interoperability between Philips and Ibex platforms, which are now more seamlessly integrated into our diagnostic workflows, will accelerate the adoption of augmented pathology tools in which we strongly believe,” said Stéphane Rossat, Innovation & Scientific Director and Project Management at Medipath. “PIPS 6.0 promises to facilitate adoption by our physicians, thanks to its streamlined navigation and optimized workflows. We are eager to contribute to the evolution toward true digital ‘cockpits,’ which will become the reference interface for our pathologists.”
Additionally, Philips is expanding cloud archival services through its collaboration with Amazon Web Services, offering secure and scalable data storage and management for growing volumes of digital pathology data.
PIPS 6.0 and the broader Philips digital pathology portfolio will be showcased at the US & Canadian Academy of Pathology (USCAP) Annual Conference in Boston from March 24–27, 2025.
References
[1] Raoux, et al. Modern Pathology (2021) 34 (suppl 2): 598-599. Ibex AI is RUO in the US.
[2] PIPS enables iSyntax files and supports third-party AI integration via SDK. PIPS 6.0 contextual launch of Ibex AI is RUO in the US.